Eisai is to work with US-based translational medicine company Aestus Therapeutics to develop novel treatments for psychiatric disorders. The companies’ …
Boyds expands Regulatory Affairs team to support growing demand
Sterling doubles ADC manufacturing capacity at Welsh facility
Femtosecond laser cuts lung tumour margin assessment time
Blood sensor detects Parkinson’s-associated proteins in 40 minutes

